Veterinary Cancer Society / Diamondback Drugs Compounding Case Study Scholarship Awards Winner
Scottsdale, AZ (PRWEB) October 29, 2014 -- The field of veterinary medicine will continue to advance at a rapid rate. Old ways of doing things become outmoded as new methodologies come to the forefront. And who better to guide the world of veterinary medicine down the path of progress than today’s young veterinary professionals? Today’s newcomers are tomorrow’s veterinarians and researchers. They’re at the forefront of cutting-edge new developments that will become standard practice in the years to come.
Because Diamondback Drugs recognizes the fact that the future of veterinary medicine rests on the shoulders of today’s newly minted veterinary professionals, they’ve created several scholarship competitions designed to educate the best and brightest on the benefits and uses of prescription compounding, which is Diamondback Drug's specialty.
One of these initiatives is the Diamondback Drugs / Veterinary Cancer Society Compounding Case Study Scholarship competition. Open to all clinical oncology residents, this contest offered a $1,000 first prize, to be used to cover expenses incurred while attending the annual Veterinary Cancer Society conference.
The conference is a wonderful opportunity for veterinary oncology specialists to network, to enhance their body of knowledge, and to mingle with luminaries in their field.
Diamondback Drugs is pleased to announce their selection of Zachary Neumann, Medical Oncology Resident at University of Illinois, as the winner of this year’s Diamondback Drugs / VCS Compounding Case Study Scholarship competition. His winning entry detailed a compelling case study, in which a Great Pyrenees dog named “Pearl” was diagnosed with osteosarcoma, but was able to enjoy her remaining months of life in a non-stressful and loving environment due to the benefits of compounded medications.
Pearl had difficulty and showed signs of stress during medication time. To further complicate matters, Pearl’s owner had physical limitations that made administering medication even more trying. While unable to completely forego oral medications, Diamondback Drugs was able to compound the medications into a smaller number of pills as well as into capsule form. This helped camouflage the taste of the medications, and reduce the stress and struggle for Pearl to take the necessary medications.
Diamondback Drugs would like to extend our sincerest congratulations and thanks to Zachary Neumann. We wish him a fun and enlightening experience at the VCS conference, and the greatest success in his career.
About Diamondback Drugs
Scottsdale, Arizona-based Diamondback Drugs specializes in the art and science of veterinary compounding. They offer home delivery, and stock the widest range of medications, chemicals, bases and flavors. Learn more about Diamondback Drugs at their website: http://www.diamondbackdrugs.com/ or call them direct at 866-578-4420.
Melissa Hofberger, Diamondback Drugs, http://www.diamondbackdrugs.com, +1 480-747-1711, [email protected]
Share this article